Perspectives in the aetiology of seronegative polyarthritis.
The concept of seronegative polyarthritis is reviewed in relation to its clinical, immunogenetic, pathological and therapeutic features.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001168:Arthritis / Q000276:immunology; D016918:Arthritis, Reactive / Q000276:immunology; D006680:HLA Antigens / Q000032:analysis; D015796:HLA-B27 Antigen; D006801:Humans; D013167:Spondylitis, Ankylosing / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D012460:Sulfasalazine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D006680:HLA Antigens; D015796:HLA-B27 Antigen; D012460:Sulfasalazine